Education
About Us
Working with TipRanks
Follow Us
Starpharma Holdings Limited (AU:SPL)
ASX:SPL
Total Valuation
Starpharma Holdings Limited has a market cap or net worth of $37.22M. The enterprise value is AU$19.34M.
Market Cap$37.22M
Enterprise ValueAU$19.34M
Share Statistics
Starpharma Holdings Limited has 418,224,800 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding418,224,800
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Starpharma Holdings Limited’s return on equity (ROE) is -0.29 and return on invested capital (ROIC) is -28.50%.
Return on Equity (ROE)-0.29
Return on Assets (ROA)-0.22
Return on Invested Capital (ROIC)-28.50%
Return on Capital Employed (ROCE)-0.50
Revenue Per Employee207.22K
Profits Per Employee-204.12K
Employee Count40
Asset Turnover0.23
Inventory Turnover0.26
Valuation Ratios
The current PE Ratio of Starpharma Holdings Limited is -4.60. Starpharma Holdings Limited’s PEG ratio is 0.09.
PE Ratio-4.60
PS Ratio6.73
PB Ratio1.34
Price to Fair Value1.34
Price to FCF-5.32
Price to Operating Cash Flow-5.38
PEG Ratio0.09
Income Statement
In the last 12 months, Starpharma Holdings Limited had revenue of 8.29M and earned -8.16M in profits. Earnings per share was -0.02.
Revenue8.29M
Gross Profit7.66M
Operating Income-15.16M
Pretax Income-13.69M
Net Income-8.16M
EBITDA-9.63M
Earnings Per Share (EPS)-0.02
Cash Flow
In the last 12 months, operating cash flow was -6.98M and capital expenditures -89.00K, giving a free cash flow of -7.07M billion.
Operating Cash Flow-6.98M
Free Cash Flow-7.07M
Free Cash Flow per Share-0.02
Dividends & Yields
Starpharma Holdings Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.32
52-Week Price Change-34.07%
50-Day Moving Average0.10
200-Day Moving Average0.10
Relative Strength Index (RSI)37.71
Average Volume (3m)180.63K
Important Dates
Starpharma Holdings Limited upcoming earnings date is Aug 20, 2025, TBA Not Confirmed.
Last Earnings DateFeb 25, 2025
Next Earnings DateAug 20, 2025
Ex-Dividend Date―
Financial Position
Starpharma Holdings Limited as a current ratio of 4.94, with Debt / Equity ratio of 12.55%
Current Ratio4.94
Quick Ratio4.58
Debt to Market Cap0.02
Net Debt to EBITDA2.06
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Starpharma Holdings Limited has paid -5.53M in taxes.
Income Tax-5.53M
Effective Tax Rate0.40
Enterprise Valuation
Starpharma Holdings Limited EV to EBITDA ratio is -1.84, with an EV/FCF ratio of -2.51.
EV to Sales2.14
EV to EBITDA-1.84
EV to Free Cash Flow-2.51
EV to Operating Cash Flow-2.54
Balance Sheet
Starpharma Holdings Limited has $23.36M in cash and marketable securities with AU$11.00K in debt, giving a net cash position of -$19.83M billion.
Cash & Marketable Securities$23.36M
Total DebtAU$11.00K
Net Cash-$19.83M
Net Cash Per Share-$0.05
Tangible Book Value Per Share$0.07
Margins
Gross margin is 32.90%, with operating margin of -182.88%, and net profit margin of -98.50%.
Gross Margin32.90%
Operating Margin-182.88%
Pretax Margin-165.18%
Net Profit Margin-98.50%
EBITDA Margin-116.20%
EBIT Margin-129.65%
Analyst Forecast
The average price target for Starpharma Holdings Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-67.07%
EPS Growth Forecast-47.32%